Patent Assignment
Reel/Frame 045963/0662
Assignment of Assignor's Interest
Recorded: 2018-06-01
Pages: 5
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Use of ERBB3 Inhibitors in the Treatment of Triple Negative and Basal-Like Breast Cancers
Application:
15/994,393 →
Publication:
US 2019/0119401
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.